Skip to main content

Table 2 Summary of HRs and their 95% CI

From: Prognostic value of low microRNA-34a expression in human gastrointestinal cancer: a systematic review and meta-analysis

Study

Year

Country

Tumor type

Outcome

HR

95% CI

NOS

Hu et al. [21]

2011

America

EC

OS

DFS

1.41

1.39

0.81–2.44

0.82–2.35

8

Lin et al. [29]

2015

China

EC

OS

3.182

1.273–10.184

6

Osawa et al. [24]

2011

Japan

GC

OS

0.2

0.06–0.68

6

Hui et al. [22]

2015

China

GC

OS

2.327

1.099–4.927

7

Wei et al. [30]

2015

China

GC

OS

2.31

0.13–40.12

8

Zhang et al. [31]

2015

China

GC

OS

1.33

1.14–1.61

8

Yang et al. [23]

2015

China

GC

OS

3.05

0.6–15.50

8

Li et al. [32]

2015

China

HCC

OS

PFS

1.81

1.22

1.03–3.18

0.92–1.62

6

Yang et al. [33]

2013

China

HCC

OS

3.54

1.67–7.52

7

Cui et al. [34]

2015

China

HCC

OS

RFS

1.44

1.49

1.13–1.72

1.15–1.79

8

Xu et al. [20]

2015

China

HCC

OS

RFS

1.96

1.96

1.04–3.57

1.10–3.45

8

Ohuchida et al. [35]

2011

Japan

PC

OS

2.92

1.303–6.295

8

Jamieson et al. [36]

2012

Scotland

PC

OS

6.67

2.684–16.573

8

Long et al. [10]

2016

China

PC

OS

1.88

1.35–2.64

8

Sun et al. [37]

2018

China

PC

OS

2.24

1.38–3.36

7

Zhang et al. [25]

2017

China

CRC

OS

1.76

1.01–3.05

6

Hasakova et al. [38]

2019

Slovakia

CRC

OS

1.34

0.65–2.75

8

Gao et al. [39]

2014

China

CRC

DFS

DFS

3.819

2.973

2.438–5.983

1.339–6.602

8

Jin et al. [11]

2013

China

GBC

OS

2.37

1.11–5.06

8

  1. Abbreviations: 95%CI 95% confidence interval, CRC colorectal cancer, DFS disease-free survival, EC esophageal cancer, GBC gallbladder cancer, GC gastric cancer, HCC hepatocellular carcinoma, HR hazard ratio, OS overall survival, PC pancreatic cancer, PFS progressive-free survival, RFS recurrence-free survival